Phibro Animal Health Corp. (PAHC)
38.82
+0.84
(+2.21%)
USD |
NASDAQ |
Oct 16, 16:00
38.83
+0.01
(+0.03%)
After-Hours: 20:00
Phibro Animal Health Cash from Investing (Quarterly) : -16.45M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.45M |
| March 31, 2026 | -16.81M |
| December 31, 2025 | -17.18M |
| September 30, 2025 | -21.01M |
| June 30, 2025 | -7.034M |
| March 31, 2025 | -18.25M |
| December 31, 2024 | -260.47M |
| September 30, 2024 | -2.93M |
| June 30, 2024 | -9.111M |
| March 31, 2024 | 1.13M |
| December 31, 2023 | -24.86M |
| September 30, 2023 | -15.35M |
| June 30, 2023 | -10.28M |
| March 31, 2023 | -37.78M |
| December 31, 2022 | -9.81M |
| September 30, 2022 | -16.15M |
| June 30, 2022 | -9.54M |
| March 31, 2022 | -9.944M |
| December 31, 2021 | 17.57M |
| September 30, 2021 | -20.67M |
| June 30, 2021 | -7.19M |
| March 31, 2021 | 9.869M |
| December 31, 2020 | -7.624M |
| September 30, 2020 | -13.64M |
| June 30, 2020 | -9.533M |
| Date | Value |
|---|---|
| March 31, 2020 | -14.15M |
| December 31, 2019 | -34.18M |
| September 30, 2019 | -62.53M |
| June 30, 2019 | 14.74M |
| March 31, 2019 | -7.948M |
| December 31, 2018 | -4.779M |
| September 30, 2018 | -16.15M |
| June 30, 2018 | -10.02M |
| March 31, 2018 | -23.02M |
| December 31, 2017 | -34.74M |
| September 30, 2017 | -16.83M |
| June 30, 2017 | -4.774M |
| March 31, 2017 | -6.403M |
| December 31, 2016 | -4.879M |
| September 30, 2016 | -5.886M |
| June 30, 2016 | -7.739M |
| March 31, 2016 | -57.66M |
| December 31, 2015 | -9.542M |
| September 30, 2015 | -7.848M |
| June 30, 2015 | -12.36M |
| March 31, 2015 | -15.19M |
| December 31, 2014 | -2.959M |
| September 30, 2014 | -3.96M |
| June 30, 2014 | -5.274M |
| March 31, 2014 | -4.381M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Globus Medical, Inc. | -129.05M |
| Corcept Therapeutics, Inc. | -29.24M |
| Zoetis, Inc. | -300.00M |
| Abbott Laboratories | -673.00M |
| Prestige Consumer Healthcare, Inc. | -1.064B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 24.09M |
| Cash from Financing (Quarterly) | -1.615M |
| Free Cash Flow | 9.866M |
| Free Cash Flow Per Share (Quarterly) | 0.1274 |
| Free Cash Flow to Equity (Quarterly) | 3.902M |
| Free Cash Flow to Firm (Quarterly) | 5.579M |
| Free Cash Flow Yield | 0.62% |